BCM
ACET icon

Bridgeway Capital Management’s Adicet Bio ACET Stock Holding History

Bridgeway Capital Management’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-56,350
Closed -$474K – 1224
2025
Q4 		$474K Hold
56,350
– – 0.01% 829
2025
Q3 		$730K Hold
56,350
– – 0.02% 744
2025
Q2 		$550K Hold
56,350
– – 0.01% 761
2025
Q1 		$681K Sell
56,350
-7,813
-12% -$112K 0.02% 692
2024
Q4 		$988K Buy
64,163
+10,938
+21% +$206K 0.02% 673
2024
Q3 		$1.23M Buy
53,225
+41,269
+345% +$924K 0.03% 632
2024
Q2 		$231K Buy
11,956
+3,843
+47% +$103K 0.01% 1024
2024
Q1 		$305K Buy
8,113
+4,688
+137% +$194K 0.01% 1036
2023
Q4 		$104K Sell
3,425
-12,150
-78% -$265K ﹤0.01% 1235
2023
Q3 		$341K Buy
+15,575
New +$550K 0.01% 984
2021
Q3 		– Sell
-1,250
Closed -$206K – 1283
2021
Q2 		$206K Sell
1,250
-268
-18% -$54.6K ﹤0.01% 1258
2021
Q1 		$318K Hold
1,518
– – 0.01% 1214
2020
Q4 		$341K Hold
1,518
– – 0.01% 1081
2020
Q3 		$289K Hold
1,518
– – 0.01% 1083
2020
Q2 		$366K Buy
+1,518
New +$298K 0.01% 966
2019
Q4 		– Sell
-848
Closed -$840K – 1304
2019
Q3 		$840K Hold
848
– – 0.01% 774
2019
Q2 		$969K Hold
848
– – 0.01% 746
2019
Q1 		$648K Hold
848
– – 0.01% 933
2018
Q4 		$819K Hold
848
– – 0.01% 810
2018
Q3 		$1.44M Hold
848
– – 0.01% 736
2018
Q2 		$869K Buy
+848
New +$913K 0.01% 928

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Bridgeway Capital Management's ACET Position: Q1 2026 in Review

Bridgeway Capital Management sold out of Adicet Bio (ACET) in Q1 2026, closing a stake of 56,350 shares — an estimated $474K sold.

Bridgeway Capital Management first reported a position in ACET in Q2 2018 and held it in 21 quarters. The position peaked at $1.44M in Q3 2018. 49 funds tracked by Wall St. Rank hold ACET as of Q1 2026.

  • Bridgeway Capital Management reported no remaining Adicet Bio position as of Q1 2026 after selling out during the quarter.
  • Bridgeway Capital Management sold 56,350 Adicet Bio shares in Q1 2026, an estimated $474K.
  • Bridgeway Capital Management first reported a position in Adicet Bio in Q2 2018 and held it in 21 quarters.
  • Bridgeway Capital Management's Adicet Bio position peaked at $1.44M in Q3 2018.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.